7 Cyanobacterial Catalase Activity Prevents Oxidative Stress Induced by Pseudomonas fluorescens DUS1-27 from Inhibiting Brassica napus L. (canola) Growth.

8 [Investigation of acute poisoning event caused by carbofuran].

9 Long-term implant fibrosis prevention in rodents and non-human primates using crystallized drug formulations.

10 'We're all in the same boat': A qualitative study on how groups work in a diabetes prevention and management programme.

11 Interventions to Prevent Nonmelanoma Skin Cancers in Recipients of a Solid Organ Transplant: Systematic Review of Randomized Controlled Trials.

12 [Outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit: Risk factors and key preventive measures for eradication in record time].

13 Collective mindfulness as a preventive strategy against workplace incidents: A comparative study of Australia and the United States

14 Nicorandil prevents doxorubicin-induced human umbilical vein endothelial cell apoptosis.

15 Demonstrating a Tool for Injection Attack Prevention in MySQL

16 Sitagliptin prevents isoproterenol-induced myocardial infarction in rats by modulating nitric oxide synthase enzymes.

17 Hydroxytyrosol prevents dermal papilla cells inflammation under oxidative stress by inducing autophagy.

18 Hydroxytyrosol prevents PM-induced adiposity and insulin resistance by restraining oxidative stress related NF-κB pathway and modulation of gut microbiota in a murine model.

19 Health benefits of olive oil and its components: Impacts on gut microbiota antioxidant activities, and prevention of noncommunicable diseases

20 Historical ethnopharmacology of the herbalists from Krummhübel in the Sudety Mountains (seventeenth to nineteenth century), Silesia.

21 A novel approach for analyzing data on recurrent events with duration to estimate the combined cumulative rate of both variables over time

22 A scoping review of mental health prevention and intervention initiatives for infants and preschoolers at risk for socio-emotional difficulties.

23 In memory of Philip F. Nolan, Founding Editor of the Journal of Loss Prevention in the Process Industries

24 Design and methods of Shape Up Under 5: Integration of systems science and community-engaged research to prevent early childhood obesity.

25 Psychosocial Risk Prevention in a Global Occupational Health Perspective. A Descriptive Analysis.

26 Smartphone geospatial apps for dengue control, prevention, prediction, and education: MOSapp, DISapp, and the mosquito perception index (MPI).

27 Lung Cancer Chemopreventive Activity of Patulin Isolated from Penicillium vulpinum

28 Efficacy and Safety of Direct Oral Anticoagulants for Secondary Prevention of Cancer-Associated Thrombosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies.

29 Novel Oral Anticoagulants for Primary Stroke Prevention in Hypertrophic Cardiomyopathy Patients With Atrial Fibrillation.

30 Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation in secondary stroke and systemic embolism prevention.

31 Vitamin K status and cardiovascular events or mortality: A meta-analysis

32 Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies

33 A New Approach to Prevent Corruption in Indonesia: A Case Study on TP4 in Central Java, Indonesia

34 Gastrointestinal events and association with initiation of treatment for osteoporosis

35 Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus

36 Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review

37 Current progress in the prevention of mother-to-child transmission of hepatitis B and resulting clinical and programmatic implications

38 Clinical utility of tafenoquine in the prevention of relapse of Plasmodium vivax malaria: a review on the mode of action and emerging trial data

39 Bezlotoxumab for the prevention of Clostridium difficile infection: a review of current evidence and safety profile

40 A systematic review and meta-analysis on the use of prophylactic topical antibiotics for the prevention of uncomplicated wound infections

41 Primaquine double dose for 7 days is inferior to single-dose treatment for 14 days in preventing Plasmodium vivax recurrent episodes in Suriname

42 Strategies for prevention of ultrasound guided prostate biopsy infections [Erratum]

43 Pelvic inflammatory disease: improving awareness, prevention, and treatment

44 Strategies for prevention of ultrasound-guided prostate biopsy infections

45 Prevention of invasive fungal infections in immunocompromised patients: the role of delayed-release posaconazole

46 Update on otitis media – prevention and treatment

47 Polypodium leucotomos Extract use to prevent and reduce the risk of infectious diseases in high performance athletes

48 Comparative efficacy of uncontrolled and controlled intermittent preventive treatment during pregnancy (IPTp) with combined use of LLTNs in high resistance area to sulfadoxine-pyrimethamine in Côte d’Ivoire

49 Critical appraisal of a quadrivalent CRM197 conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo®) in the context of treatment and prevention of invasive disease

50 Current strategies for the prevention and management of central line-associated bloodstream infections

51 Prevention strategies for antimicrobial resistance: a systematic review of the literature

52 Emerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma

53 Heart failure self-care interventions to reduce clinical events and symptom burden

54 Impact of rivaroxaban on stent thrombosis and secondary prevention of cardiovascular events in acute coronary syndrome

55 Transitioning from population to individualized preventive cardiology

56 Anacetrapib: potential for the prevention and treatment of coronary heart disease

57 Dabigatran for prophylaxis of thromboembolic events in patients with atrial fibrillation

58 Emerging options to prevent stroke in atrial fibrillation patients

59 Dabigatran and other oral antithrombotic agents for the prevention of stroke in patients with atrial fibrillation

60 Gastrointestinal events and association with initiation of treatment for osteoporosis

61 Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus

62 Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review

63 Gastrointestinal events and association with initiation of treatment for osteoporosis

64 Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus

65 Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review

66 A Plurisensorial Device to Support Human Smell in Hazardous Environment and Prevent Respiratory Disease

67 Prevention of Calcium Nephrolithiasis: The Influence of Diuresis on Calcium Oxalate Crystallization in Urine

68 Pros and Cons of Aspirin Prophylaxis for Prevention of Cardiovascular Events in Kidney Transplantation and Review of Evidence

69 Risk Factors and Prevention Strategies of Nosocomial Infection in Geriatric Patients

70 Current progress in the prevention of mother-to-child transmission of hepatitis B and resulting clinical and programmatic implications

71 Clinical utility of tafenoquine in the prevention of relapse of Plasmodium vivax malaria: a review on the mode of action and emerging trial data

72 Bezlotoxumab for the prevention of Clostridium difficile infection: a review of current evidence and safety profile

73 A systematic review and meta-analysis on the use of prophylactic topical antibiotics for the prevention of uncomplicated wound infections

74 Preventive Effect of the Herbal Preparation, HemoHIM, on Cisplatin-Induced Immune Suppression

75 Primaquine double dose for 7 days is inferior to single-dose treatment for 14 days in preventing Plasmodium vivax recurrent episodes in Suriname

76 Strategies for prevention of ultrasound guided prostate biopsy infections [Erratum]

77 Pelvic inflammatory disease: improving awareness, prevention, and treatment

78 Prevention of invasive fungal infections in immunocompromised patients: the role of delayed-release posaconazole

79 Update on otitis media – prevention and treatment

80 Polypodium leucotomos Extract use to prevent and reduce the risk of infectious diseases in high performance athletes

81 Comparative efficacy of uncontrolled and controlled intermittent preventive treatment during pregnancy (IPTp) with combined use of LLTNs in high resistance area to sulfadoxine-pyrimethamine in Côte d’Ivoire

82 Critical appraisal of a quadrivalent CRM197 conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo®) in the context of treatment and prevention of invasive disease

83 Current strategies for the prevention and management of central line-associated bloodstream infections

84 Prevention strategies for antimicrobial resistance: a systematic review of the literature

85 Awareness and Malaria Prevention Practices in a Rural Community in the Ho Municipality, Ghana

86 Breast Cancer Survivors’ Perceptions of Prevention versus Control of Future Cancer Recurrence

87 Targeting HIF-1α to Prevent Renal Ischemia-Reperfusion Injury: Does It Work?

88 Glucocorticoid Receptor Antagonist Administration Prevents Adrenal Gland Atrophy in an ACTH-Independent Cushing’s Syndrome Rat Model

89 The Mitla Landslide, an Event That Changed the Fate of a Mixteco/Zapoteco Civilization in Mesoamerica

90 The Clinical Rationale for the Sentry Bioconvertible Inferior Vena Cava Filter for the Prevention of Pulmonary Embolism

91 Emerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma

92 Heart failure self-care interventions to reduce clinical events and symptom burden

93 Impact of rivaroxaban on stent thrombosis and secondary prevention of cardiovascular events in acute coronary syndrome

94 Transitioning from population to individualized preventive cardiology

95 Anacetrapib: potential for the prevention and treatment of coronary heart disease

96 Dabigatran for prophylaxis of thromboembolic events in patients with atrial fibrillation

97 Emerging options to prevent stroke in atrial fibrillation patients

98 Dabigatran and other oral antithrombotic agents for the prevention of stroke in patients with atrial fibrillation

99 [PREVENTION OF ALLERGIC DISEASES].

100 Extreme Risk Protection Orders Intended to Prevent Mass Shootings: A Case Series.

101 Multiple session early psychological interventions for the prevention of post-traumatic stress disorder.

Keyword Connections

Journals

Research Groups

Bibliographies